Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Kiromic Biopharma Inc (OP: KRBP )

1.750 +0.690 (+65.09%)
Streaming Delayed Price Updated: 12:22 PM EDT, Aug 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,624
Open 1.500
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.060
Today's Range 1.490 - 2.020
52wk Range 0.1600 - 3.780
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kiromic BioPharma’s Deltacel Receives FDA Fast Track Designation
From Kiromic BioPharma, Inc.
Via Business Wire
KRBP Stock Earnings: Kiromic BioPharma Reported Results for Q2 2024
Kiromic BioPharma just reported results for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
+89.19%
+89.19%
1 Month
-16.67%
-16.67%
3 Month
-36.59%
-36.59%
6 Month
-31.70%
-31.70%
1 Year
+191.67%
+191.67%

More News

Read More
Kiromic BioPharma Provides Update on Part 1 of the Deltacel-01 Trial
From Kiromic BioPharma, Inc.
Via Business Wire
Kiromic BioPharma Reports 20% Tumor Size Reduction at Eight Months in First Patient Enrolled in Deltacel-01
From Kiromic BioPharma, Inc.
Via Business Wire
Kiromic BioPharma to Advance Deltacel-01 Clinical Trial to Part 2, Expansion Phase
From Kiromic BioPharma, Inc.
Via Business Wire
Kiromic BioPharma Provides Updates on its Deltacel-01 Clinical Trial
From Kiromic BioPharma, Inc.
Via Business Wire
Kiromic BioPharma Reports Six-Month Results from First Patient Enrolled in Deltacel-01 Clinical Trial
From Kiromic BioPharma, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.